节点文献

人乳头瘤病毒疫苗临床应用中国专家共识

Chinese expert consensus on clinical application of human papilloma virus vaccine

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【摘要】 人乳头瘤病毒(human papilloma virus,HPV)疫苗接种是预防HPV感染和相关疾病的有效方法,是防控HPV感染相关疾病的一级预防措施。低龄人群接种HPV疫苗的效果优于高龄人群,性暴露前接种免疫效果最佳。HPV疫苗不仅适用于一般普通人群,同样推荐用于高危、特殊人群。对具有遗传易感、高危生活方式和人类免疫缺陷病毒感染的适龄女性应优先推荐接种HPV疫苗。不论是否有HPV感染、细胞学是否异常的适龄女性均可接种HPV疫苗。近期有妊娠计划和妊娠期、哺乳期女性不宜接种HPV疫苗。接种HPV疫苗后仍应进行子宫颈癌筛查。

【Abstract】 Human papilloma virus (HPV) vaccination is an effective method to prevent HPV infection and the related diseases,and is a primary preventive measure for HPV infection related diseases.The vaccination effect of young women is better,and the immune efficacy of vaccination for teenagers before sexual exposure is the best.HPV vaccine is not only suitable for the general population,but also recommended for high-risk and special groups.HPV vaccination should be recommended for women in appropriate age with genetic susceptibility,high-risk lifestyle and human immunodeficiency virus infection.No matter whether they have HPV infection or abnormal cytology,suitable-age women can be vaccinated.Women with pregnancy plan in the near future,or pregnant and lactating women should not be vaccinated.Cervical cancer screening recommendations should be carried out after HPV vaccination.

【基金】 国家自然科学基金重点项目(81630060);国家自然科学基金面上项目(81974410);妇幼健康研究会研究项目(2018AMCHS008);浙江省科技厅重点研发项目(2020C03025);上海市科学技术委员会科研计划项目(18411963600)
  • 【文献出处】 中国医学前沿杂志(电子版) ,Chinese Journal of the Frontiers of Medical Science(Electronic Version) , 编辑部邮箱 ,2021年02期
  • 【分类号】R737.33
  • 【被引频次】16
  • 【下载频次】1148
节点文献中: 

本文链接的文献网络图示:

本文的引文网络